156 related articles for article (PubMed ID: 27180105)
1. Long noncoding RNAs: Novel molecules in cardiovascular biology, disease and regeneration.
Hou J; Zhou C; Long H; Zheng S; Guo T; Wu Q; Wu H; Zhong T; Wang T
Exp Mol Pathol; 2016 Jun; 100(3):493-501. PubMed ID: 27180105
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of long noncoding RNA function in development and disease.
Schmitz SU; Grote P; Herrmann BG
Cell Mol Life Sci; 2016 Jul; 73(13):2491-509. PubMed ID: 27007508
[TBL] [Abstract][Full Text] [Related]
3. Noncoding RNAs in vascular disease.
Leung A; Natarajan R
Curr Opin Cardiol; 2014 May; 29(3):199-206. PubMed ID: 24614861
[TBL] [Abstract][Full Text] [Related]
4. The role and medical prospects of long non-coding RNAs in cardiovascular disease.
Kim N; Chung WY; Cho JY
Heart Fail Rev; 2023 Nov; 28(6):1437-1453. PubMed ID: 37796408
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs in cardiovascular disease, diagnosis, and therapy.
Haemmig S; Simion V; Yang D; Deng Y; Feinberg MW
Curr Opin Cardiol; 2017 Nov; 32(6):776-783. PubMed ID: 28786864
[TBL] [Abstract][Full Text] [Related]
6. Endothelial function and dysfunction in the cardiovascular system: the long non-coding road.
Monteiro JP; Bennett M; Rodor J; Caudrillier A; Ulitsky I; Baker AH
Cardiovasc Res; 2019 Oct; 115(12):1692-1704. PubMed ID: 31214683
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Long Noncoding RNAs in Tissue Regeneration and Senescence.
Tavares E Silva J; Pessoa J; Nóbrega-Pereira S; Bernardes de Jesus B
Cells; 2024 Jan; 13(2):. PubMed ID: 38247811
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on HOX cluster‑embedded antisense lncRNAs in cardiovascular diseases (Review).
Zhou Y; Wu Q
Int J Mol Med; 2023 Dec; 52(6):. PubMed ID: 37830159
[TBL] [Abstract][Full Text] [Related]
9. Application of New Lineage Tracing Techniques in Cardiovascular Development and Physiology.
Zhang M; Lui KO; Zhou B
Circ Res; 2024 Feb; 134(4):445-458. PubMed ID: 38359092
[TBL] [Abstract][Full Text] [Related]
10. Leveraging non-coding RNAs to fight cardiovascular disease: the EU-CardioRNA network.
Robinson EL; Emanueli C; Martelli F; Devaux Y
Eur Heart J; 2021 Dec; 42(48):4881-4883. PubMed ID: 34109376
[No Abstract] [Full Text] [Related]
11. Global position paper on cardiovascular regenerative medicine.
Fernández-Avilés F; Sanz-Ruiz R; Climent AM; Badimon L; Bolli R; Charron D; Fuster V; Janssens S; Kastrup J; Kim HS; Lüscher TF; Martin JF; Menasché P; Simari RD; Stone GW; Terzic A; Willerson JT; Wu JC; ; ; ; ; ; ; ; ; ;
Eur Heart J; 2017 Sep; 38(33):2532-2546. PubMed ID: 28575280
[No Abstract] [Full Text] [Related]
12. Live cell screening platform identifies PPARδ as a regulator of cardiomyocyte proliferation and cardiac repair.
Magadum A; Ding Y; He L; Kim T; Vasudevarao MD; Long Q; Yang K; Wickramasinghe N; Renikunta HV; Dubois N; Weidinger G; Yang Q; Engel FB
Cell Res; 2017 Aug; 27(8):1002-1019. PubMed ID: 28621328
[TBL] [Abstract][Full Text] [Related]
13. MALAT1 knockdown alleviates myocardial injury in mice with severe acute pancreatitis via the miR-374a/Sp1/Wnt/β-catenin pathway.
Sun Y; Gu R; Shen Z; Ye Y
Am J Transl Res; 2023; 15(6):3928-3941. PubMed ID: 37434842
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA BBOX1-AS1 promotes the progression of gastric cancer by regulating the miR-361-3p/Mucin 13 signaling axis.
Cai T; Peng B; Hu J; He Y
Bioengineered; 2022 May; 13(5):13407-13421. PubMed ID: 36700475
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine promotes cell proliferation and inhibits cell apoptosis by regulating LINC00982 and activating the phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signaling in hypoxia/reoxygenation-induced H9c2 cells.
Wang T; Li Z; Xia S; Xu Z; Chen X; Sun H
Bioengineered; 2022 Apr; 13(4):10159-10167. PubMed ID: 35466860
[TBL] [Abstract][Full Text] [Related]
16. MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p.
Wang P; Bai C; Shen S; Jiang C; Deng J; Han D
Open Med (Wars); 2021; 16(1):1653-1667. PubMed ID: 34761116
[TBL] [Abstract][Full Text] [Related]
17. LncRNAs Participate in Post-Resuscitation Myocardial Dysfunction Through the PI3K/Akt Signaling Pathway in a Rat Model of Cardiac Arrest and Cardiopulmonary Resuscitation.
Hou J; Zeng C; Zheng G; Liang L; Jiang L; Yang Z
Front Physiol; 2021; 12():689531. PubMed ID: 34194340
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA H19 protects H9c2 cells against hypoxia‑induced injury by activating the PI3K/AKT and ERK/p38 pathways.
Yuan L; Yu L; Zhang J; Zhou Z; Li C; Zhou B; Hu X; Xu G; Tang Y
Mol Med Rep; 2020 Apr; 21(4):1709-1716. PubMed ID: 32319634
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs: How to regulate the metastasis of non-small-cell lung cancer.
Fang C; Wang L; Gong C; Wu W; Yao C; Zhu S
J Cell Mol Med; 2020 Mar; 24(6):3282-3291. PubMed ID: 32048814
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 prevents the protective effects of miR-125b-5p against acute myocardial infarction through positive regulation of NLRC5.
Liu Z; Liu J; Wei Y; Xu J; Wang Z; Wang P; Sun H; Song Z; Liu Q
Exp Ther Med; 2020 Feb; 19(2):990-998. PubMed ID: 32010261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
